Jim Kershaw

Statistics

Publications

Citations

H-Index

Active since

1986

Affiliations

Sanofi (United States)(Current)

Adelphi Group (United Kingdom)

Regeneron (United States)

Jim Kershaw is an author at Sanofi (United States) specializing in medicine, conventional synthetic disease-modifying antirheumatic drugs, and clinical pharmacology.

Publications per year

1986–2020

Publications

Hodgkin's disease of the nasopharynx

B. J. O’Reilly, Jim Kershaw · The Journal of Laryngology & Otology · 1987 · 24 citations

Medicine, Immunology, Pathology +4

Biologic Disease-Modifying Antirheumatic Drug Prescription Patterns Among Rheumatologists in Europe and Japan

E Sullivan, Jim Kershaw, Stuart Blackburn et al. · Rheumatology and Therapy · 2020 · 22 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +14

Biologic Disease-Modifying Antirheumatic Drug Prescription Patterns for Rheumatoid Arthritis Among United States Physicians

E Sullivan, Jim Kershaw, Stuart Blackburn et al. · Rheumatology and Therapy · 2020 · 21 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +14

Failure of radiotherapy to reverse progressive pulmonary fibrosis caused by paraquat

Lionel L.O. Bloodworth, Jim Kershaw, P. E. Stevens et al. · British Journal of Radiology · 1986 · 10 citations

Medicine, Clinical Toxicology, Toxicology +13

1–4 of 4